Commodore Capital LP 13D and 13G filings for Vera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:10 pm Sale |
2024-09-30 | 13G | Vera Therapeutics, Inc. VERA |
Commodore Capital LP | 2,475,000 4.500% |
-1,425,000 (-36.54%) |
Filing |
| 2024-11-14 4:05 pm Sale |
2024-02-29 | 13G | Vera Therapeutics, Inc. VERA |
Commodore Capital LP | 3,900,000 7.300% |
-1,550,000 (-28.44%) |
Filing |
| 2024-02-14 4:10 pm Purchase |
2023-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Commodore Capital LP | 5,450,000 12.300% |
448,217 (+8.96%) |
Filing |
| 2024-02-14 4:05 pm Purchase |
2023-06-14 | 13G | Vera Therapeutics, Inc. VERA |
Commodore Capital LP | 5,001,783 11.300% |
2,658,926 (+113.49%) |
Filing |
| 2023-02-16 4:05 pm Purchase |
2023-02-06 | 13G | Vera Therapeutics, Inc. VERA |
Commodore Capital LP | 2,342,857 5.600% |
2,342,857 (New Position) |
Filing |